Research demonstrates clinical and economic benefits of implementing NIPT into NHS care pathway
16 Sep 2016, 11:10 a.m.
The UK National Screening Committee, based on a research programme led by BRC-funded Professor Lynn Chitty, has recommended to the Government that NIPT for Down’s Syndrome be implemented into the NHS maternity care pathway and is currently awaiting minist
Construction underway of Zayed Centre featuring new ‘cleanrooms’ for the production of gene and cell therapy medicinal products
16 Sep 2016, 11:06 a.m.
The Zayed Centre for Research into Rare Disease in Children (ZCR) is currently under construction in Guildford Street. Importantly this will include a dedicated facility comprising seven ‘cleanrooms’ where gene and cell therapy medicinal products can be m
SCIDNET is a European Commission Horizon 2020 -funded project which launched in January 2016. It aims to take gene therapy from current clinical trials to a medicinal product that can be delivered to any child in the EU. It follows on from previous EU col
The importance of prognostic biomarkers in improving risk stratification in Wilms’ Tumour
16 Sep 2016, 11:03 a.m.
Research led by BRC funded Professor Kathy Pritchard-Jones has demonstrated the importance of prognostic biomarkers in improving risk stratification in Wilms’ Tumour (WT).
NICE recommend drug trialled at GOSH for the treatment of Duchenne Muscular Dystrophy
16 Sep 2016, 11:02 a.m.
NICE have published final guidance recommending ataluren for the treatment of Duchenne Muscular Dystrophy (DMD) caused by a nonsense mutation, in children aged 5 years and over who are able to walk.